Bill Tracker
Health Facilities

AB 2300 (Wilson, D-Suisun City)

Pending Follow

AB 2300 (Wilson, D-Suisun City) Details

Passed the Senate Environmental Quality Committee on July 3. Pending a Senate floor vote.

AB 2300 would phase out the manufacture, sale, or distribution of IV bags and IV tubing made with intentionally added Di (2-ethylhexyl) phthalate (DEHP). Beginning Jan. 1, 2030, the manufacture, sale, or distribution of IV bags with intentionally added DEPH would be prohibited. Manufacturers would be able to extend this deadline to 2032 if they meet public disclosure criteria. Beginning Jan. 1, 2035, this prohibition would be extended to all IV tubing. Certain blood kits, bags, and tubing would be exempted from this prohibition.

Vanessa Gonzalez

Job title:
VP State Advocacy
Phone number:

Savannah Tapia

Job title:
Policy Associate
Phone number: